WCLC 2022 | Chemotherapy in elderly patients with NSCLC

Rajwanth Veluswamy, MD, Icahn School of Medicine at Mount Sinai, New York, NY, discusses chemotherapy in elderly patients with non-small cell cancer (NSCLC). The median age of lung cancer diagnosis is 70 in theUSA, however, elderly patients are frequently excluded from clinical trials, resulting in a lack of data to predict treatment outcomes in this patient population. Interview took place at the IASLC 2022 World Conference on Lung Cancer congress in Vienna, Austria.